Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Riassunto 
Founder of 5 different companies, notably: ARYA Sciences Acquisition Corp., ARYA Sciences Acquisition Corp. II and ARYA Sciences Acquisition Corp. III, Michael R. Altman is an entrepreneur and currently occupies the position of Chief Financial Officer & Director at ARYA Sciences Acquisition Corp. IV (which he founded in 2020), Chief Financial Office & Director at ARYA Sciences Acquisition Corp. V (which he founded in 2021) and Managing Director at Perceptive Advisors LLC, Managing Director at Perceptive Advisors (Private Equity) (a subsidiary of Perceptive Advisors LLC). Mr. Altman is also on the board of Vitruvias Therapeutics LLC (former Chairman), Lyra Therapeutics, Inc., Covid Apollo Project LLC and Nautilus Biotechnology, Inc.

Michael R. Altman previously occupied the position of Vice President of Mako Merger Sub, Inc., Chief Financial Officer & Director at ARYA Sciences Acquisition Corp. (he founded the company in 2018), Chief Financial Officer & Director at ARYA Sciences Acquisition Corp. II (he founded the company in 2020), Chief Financial Officer & Director at ARYA Sciences Acquisition Corp. III (he founded the company in 2020) and Healthcare Analyst at First New York Securities LLC.

Michael R. Altman received an undergraduate degree from the University of Vermont.


Posti e reponsabilitÓ di Michael R. Altman 
NomeTitolo Da
Nautilus Biotechnology, Inc.
(Biotecnologia)
Independent Director 2021
ARYA Sciences Acquisition Corp IV
(SocietÓ Holding)
Chief Financial Officer & Director 2021
ARYA Sciences Acquisition Corp V
(SocietÓ Holding)
Chief Financial Office & Director 2021
Lyra Therapeutics, Inc.
(Biotecnologia)
Independent Director 2018
Vitruvias Therapeutics LLC Director -
Covid Apollo Project LLC Director -
Perceptive Advisors LLC Managing Director 2019
Perceptive Advisors (Private Equity) Managing Director -


Participazioni di Michael R. Altman 
NomeAzioni%Valorizzazione
ARYA Sciences Acquisition Corp V (ARYE)
(SocietÓ Holding)
499 0003,23%4 915 150 USD
Lyra Therapeutics, Inc. (LYRA)
(Biotecnologia)
00,0000%0 USD


Michael R. Altman: network personale 
Le notizie pi¨ lette 
12/10CATHIE WOOD: Wood di ARK Invest avverte che la prossima flessione economica in Cina è "ovvia".
MR
12/10JAMIE DIMON: JPMorgan's Dimon fa esplodere il bitcoin come "senza valore", dovuto alla regolamentazione
MR
15/10JACK DORSEY: Il CEO di Square Dorsey dice che sta cercando di costruire un sistema di estrazione di bitcoin - tweet
MR
13/10WARREN BUFFETT: Nubank, sostenuta da Buffett, realizza un profitto in Brasile
MR
04/10ELON MUSK: Gli investitori sostengono che Musk dovrebbe rimborsare 9,4 miliardi di dollari a Tesla per l'affare SolarCity
MR
03/10WARREN BUFFETT: Esclusivo-Southwest Gas si avvicina all'affare Questar dopo che Buffett ha perso le risorse
MR
11/10JAMIE DIMON: JPMorgan's Dimon fa esplodere il bitcoin come "senza valore
MR
07/10ROBERT WALTERS: Il reclutatore Robert Walters si aspetta che il profitto batta le stime in mezzo al caldo mercato del lavoro
MR
06/10CARL ICAHN: Dominion venderà Questar a Southwest Gas in un affare da quasi 2 miliardi di dollari
MR
08/10LEONARDO DEL VECCHIO: Generali, Del Vecchio arrotonda quota di ulteriore 0,08%, sale al 5,4%
RE
Pi¨ notizie


© 2021 People and Ownership :   
Michael R. Altman : connessioni